Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

Trial Profile

Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2018

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Bronchiolitis
  • Focus Registrational; Therapeutic Use
  • Acronyms NO-BRO
  • Sponsors AIT
  • Most Recent Events

    • 13 Jun 2018 Based on AIT Therapeutics media release, status changed from recruiting to completed.
    • 13 Jun 2018 Primary endpoint (Hospital Length of Stay (LOS)) has not been met, according to an AIT Therapeutics media release.
    • 13 Jun 2018 Top-line results presented in an AIT Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top